VECORT 20ml

 Vecort 20ml used in cattle, horses, pigs, dogs, cats and foxes. – cattle: retention and postpartum paralysis, in udder diseases, inflammation of joints, tendons, muscles, foot rot, primary ketosis. – horses: in laminitis, myomatosis, arthritis, muscles, tendons, subcutaneous connective tissue, allergic and post-traumatic skin diseases. – pigs: edema disease, inflammation of the muscles, joints, tendons, conjunctivitis, foreskin, postpartum dairy, MMA syndrome. – dogs, cats, foxes: inflammation of joints, muscles, tendons, hair follicles, ears, lungs and bronchi, allergic diseases.

VECORT 20ml PRODUCT DESCRIPTION

Flumetazon 0.5 mg/ml, injection solution for dogs, cats and foxes

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Marketing authorisation holder and manufacturer responsible for batch release:

Biowet Puławy Sp. z o.o.
ul. Arciucha 2, 24-100 Puławy

2. 2. NAME OF THE VETERINARY MEDICINAL PRODUCT

Vecort, 0.5 mg/ml, injection solution for dogs, cats and foxes

3. QUALITATIVE AND QUANTITATIVE COMPOSITION OF THE ACTIVE SUBSTANCE(S)

Flumethasone 0.5 mg / ml

4. INDICATIONS

The medicine is intended to be used in the course of:

• rheumatoid conditions,
• allergy and inflammation related dermatological conditions,
• muscle, joint and tendon inflammation,
• respiratory system disorders and mastitis.

 

5. CONTRAINDICATIONS

Hypersensitivity to flumethasone or any of the components of the product.

General contraindications for the use of glucocorticosteroids also apply to Vecort.

Do not use the drug in cases of: stomach and intestinal ulcers, viral infections, systemic mycoses, pregnancy, hypocalcaemia, osteoporosis, cataracts, glaucoma, poorly healing wounds.

Vecort should not be used in the case of bacterial infections until an effective antibiotic therapy has been applied.

 

6. ADVERSE REACTIONS

Like all medicines, Vecort can cause adverse reactions.

An increased demand for water, polyuria and increased appetite may occur.

Stomach and intestinal ulcerations, osteoporosis, growth retardation in young animals may occur. Glucocorticosteroids can cause reversible damage to the liver, hypertension, increased risk of thrombosis, development of cataract, prolonged wound healing.

In long-term treatment with glucocorticosteroids, iatrogenic Cushing’s syndrome may occur. Long-term glucocorticosteroid therapy may cause immunosuppression.

A prolonged use of the drug leads to a decrease in adrenal cortex activity and may even lead to atrophy.

Administration of glucocorticosteroids may affect the results of blood laboratory tests causing: increased activity of alkaline phosphatase, increased glucose concentration, decreased concentration total and free T₄, leucocytosis. Glucocorticosteroids affect the results of tests that assess the activity of the hypothalamo-pituitary-adrenal system and the results of allergic skin tests.

The occurrence of adverse reactions after the administration of this product, or any observed symptoms that cause worry not mentioned in the leaflet (including human reactions due to contact with the medicine), must be reported to a competent veterinarian, the holder of the authorisation or the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. A notification form is to be downloaded